Company / Working Capital per Share
Immunome Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$9.55
FY2025
5-year range
$1.26 / $10.13
FY2021-FY2025
Trend
+147.4%
vs FY2024
Sector context
#53 of 210
Health Care
What the data says
Immunome Inc.'s working capital per share of $9.55 is higher than 75% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 7 years, ranging from $1.26 in FY2022 to $11.76 in FY2020.
Based on SEC 10-K filings.
9.55 in FY2025 with a 5-year CAGR of -4.1%. Top quartile in the Health Care sector.
Declined from $10.13 to $9.55 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +96.3%
- 5-Year CAGR
- -4.1%
- 10-Year CAGR
- -
Sector benchmark
-91.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 147.4% year-over-year.
- Ranks #53 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.55 | +147.4% |
| FY2024 | $3.86 | -61.9% |
| FY2023 | $10.13 | +702.0% |
| FY2022 | $1.26 | -68.9% |
| FY2021 | $4.07 | -65.4% |
| FY2020 | $11.76 | +782.9% |
| FY2019 | $1.33 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026